Almost Family Upgraded by Zacks to “Outperform” (AFAM)
Almost Family (NASDAQ:AFAM) was upgraded by Zacks from an “underperform” rating to an “outperform” rating in a report issued on Friday. The firm currently has a $22.30 price target on the stock. Zacks‘s price target would indicate a potential upside of 4.89% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Avondale Partners downgraded shares of Almost Family from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 22nd. Separately, analysts at Piper Jaffray reiterated a “neutral” rating on shares of Almost Family in a research note on Friday, May 9th. They now have a $24.00 price target on the stock, down previously from $25.00. Finally, analysts at RBC Capital cut their price target on shares of Almost Family from $28.00 to $25.00 in a research note on Wednesday, March 12th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $22.08.
Almost Family (NASDAQ:AFAM) traded down 0.56% on Friday, hitting $21.14. 25,441 shares of the company’s stock traded hands. Almost Family has a 1-year low of $17.66 and a 1-year high of $33.97. The stock’s 50-day moving average is $21.49 and its 200-day moving average is $26.34. The company has a market cap of $197.1 million and a P/E ratio of 32.36.
Almost Family (NASDAQ:AFAM) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.30 by $0.04. The company had revenue of $120.00 million for the quarter, compared to the consensus estimate of $122.55 million. On average, analysts predict that Almost Family will post $1.42 earnings per share for the current fiscal year.
Almost Family, Inc, along with its subsidiaries, is a regionally focused provider of home health services.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.